Anamorelin drug introduction and correct usage and dosage

Anamorelin (Anamorelin) is an innovative oral drug mainly used to treat cancer cachexia in patients with a variety of malignant tumors, such as non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer, etc. Cancer cachexia is a common complication of cancer, characterized by rapid weight loss, muscle wasting, and loss of appetite, which seriously affects patients' quality of life and treatment effects. Anamorelin helps improve nutritional status and quality of life in patients with cancer cachexia by activating ghrelin receptors, stimulating appetite, increasing body weight and muscle mass.

1. Basic information about drugs

Anamulin, trade nameAdlumiz, is a ghrelin receptor agonist. It improves cachexia symptoms by simulating the body's secretion of ghrelin to stimulate appetite, increase body weight and muscle mass. Anamorelin was launched in Japan in 2021, becoming the world's first drug specifically to treat cachexia.

2. Correct usage and dosage

1. Dosage and administration: For adults, the recommended dose of anamorelin is 100 mg (usually 2 tablets) per time, once a day, on an empty stomach. You should avoid eating within one hour after taking the medicine to avoid affecting the absorption of the medicine. If you forget to take a dose, you should take it on an empty stomach as soon as you remember, but you should not take two doses at once.

2. Things to note:

1) If you accidentally take more than the prescribed dose of anamorelin, you should consult your doctor or pharmacist immediately.

2) While taking Anamorelin, you should avoid drinking grapefruit juice or eating any food containing St. John's Wort, as these may affect the efficacy of the medicine.

3) If there is no weight gain or appetite improvement within three weeks after administration, in principle, the use of anamorelin should be stopped.

4)For patients who have been taking it for more than 12 weeks, their weight and appetite should be checked through an interview to assess whether it is necessary to continue treatment.

3. Side effects and monitoring

Anamorelin may cause some side effects during treatment, such as nausea, vomiting, diarrhea, loss of appetite, and fatigue. These side effects are usually temporary and can be relieved with appropriate dose adjustments or other medications. During the use of anamorelin, patients should undergo regular blood glucose and liver function monitoring, as well as electrocardiogram examinations to ensure the safety and effectiveness of the drug.

In conclusion, anamorelin, as a new cancer cachexia treatment drug, provides a new treatment option for cancer patients. However, correct usage, dosage and precautions are crucial to ensure drug efficacy and safety. When using anamorelin, patients should strictly follow the doctor's instructions and closely monitor their own reactions and changes in their condition.